Journal article

Comparative efficacy and acceptability of antidepressant drugs in the acute treatment of major depressive disorder: A network meta-analysis

Abstract:: Background

Major depressive disorder is one of the most common, burdensome and costly psychiatric disorders worldwide in adults. Both pharmacological and non-pharmacological treatments are available, however, because of lack of resources, antidepressants are used more frequently. Prescription of these agents should be informed by the best available evidence. Consequently, we aimed to update and expand our previous work to compare and rank antidepressants for major depressive diso...
Expand abstract
Collapse abstract

Publication status:: Published

Peer review status:: Peer reviewed

Actions

Email

Email this record

Send the bibliographic details of this record to your email address.

Your Email
Please enter the email address that the record information will be sent to.

-
Your message (optional)
Please add any additional information to be included within the email.
Cite

Cite this record

APA Style

Cipriani, A., Furukawa, T., Salanti, G., Chaimani, A., Atkinson, L., Ogawa, Y., Leucht, S., Ruhe, H., Turner, E., Higgins, J., Egger, M., Takeshima, N., Hayasaka, Y., Imai, H., Shinohara, K., Tajika, A., Ioannidis, J., & Geddes, J. (2018). Comparative efficacy and acceptability of antidepressant drugs in the acute treatment of major depressive disorder: A network meta-analysis. Lancet.

MLA Style

Cipriani, A., et al. “Comparative Efficacy and Acceptability of Antidepressant Drugs in the Acute Treatment of Major Depressive Disorder: A Network Meta-Analysis.” Lancet, Elsevier, 2018.

Chicago Style

Cipriani, A, T Furukawa, G Salanti, A Chaimani, L Atkinson, Y Ogawa, S Leucht, et al. 2018. “Comparative Efficacy and Acceptability of Antidepressant Drugs in the Acute Treatment of Major Depressive Disorder: A Network Meta-Analysis.” Lancet.
Share
Print

Access Document

Files:: Cipriani et al, Comparative efficacy and acceptability of anti...

(Preview, Version of record, pdf, 671.5KB, Terms of use)

Publisher copy:: 10.1016/S0140-6736(17)32802-7

Authors

+ Cipriani, A More by this author

Institution:: University of Oxford
Division:: MSD
Department:: Psychiatry
Role:: Author

+ Furukawa, T More by this author

Role:: Author

+ Salanti, G More by this author

Role:: Author

+ Chaimani, A More by this author

Role:: Author

+ Atkinson, L More by this author

Institution:: University of Oxford
Division:: Medical Sciences Division
Department:: Psychiatry
Role:: Author

More authors...

+ National Institute for Health Research More from this funder

Publisher:: Elsevier
Journal:: Lancet More from this journal
Publication date:: 2018-02-01
Acceptance date:: 2017-10-05
DOI:: 10.1016/S0140-6736(17)32802-7
EISSN:: 1474-547X
ISSN:: 0140-6736

Pubs id:: pubs:734788
UUID:: uuid:95a796fa-e842-4e11-bee6-b0b2237a2541
Local pid:: pubs:734788
Source identifiers:: 734788
Deposit date:: 2017-10-09

Terms of use

Copyright holder:: Cipriani et al
Copyright date:: 2018
Notes:: © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license

Licence:: CC Attribution (CC BY)

Views and Downloads

About views and downloads

If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP